AlphaFold predicted structure
CYP2R1 · Q6VVX0

Mean pLDDT
96.3/ 100
Very high
501 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)5%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytochrome P450 family 2 subfamily R member 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Hypophosphataemia or rickets
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalRetinal disorders
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHypocalcemic vitamin D-dependent rickets
vitamin D deficiency
vitamin deficiency disorder
rickets
alcohol drinking
urolithiasis
COVID-19
vitamin D-dependent rickets, type 1
Vogt-Koyanagi-Harada disease
squamous cell carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Vitamin D 25-hydroxylase
A cytochrome P450 monooxygenase involved in activation of vitamin D precursors. Catalyzes hydroxylation at C-25 of both forms of vitamin D, vitamin D(2) and D(3) (calciol) (PubMed:12867411, PubMed:15465040, PubMed:18511070). Can metabolize vitamin D analogs/prodrugs 1alpha-hydroxyvitamin D(2) (doxercalciferol) and 1alpha-hydroxyvitamin D(3) (alfacalcidol) forming 25-hydroxy derivatives (PubMed:15465040, PubMed:18511070). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:12867411, PubMed:15465040, PubMed:18511070)
CYP2R1 · Q6VVX0

Mean pLDDT
96.3/ 100
Very high
501 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0